Hosted on MSN1mon
Combining ctDNA and genomic profiling predicts cancer relapse and treatment responseMore information: Taiga Sasaki et al, Comprehensive Genome Profiling‐Initiated Tumor‐Informed Circulating Tumor DNA Monitoring for Patients With Advanced Cancer, Cancer Science (2025).
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
We tested the hypothesis that genomic profiling of metastatic colorectal cancer is dependent on gender. Materials & methods: A total of 152 patients with metastatic colorectal cancer who were ...
A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...
A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...
Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...
In 2019, cancer genomic profiling tests became eligible for public health care insurance system coverage for patients in advanced stages of cancer, greatly increasing the use of the new therapy.
Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results